US-based consumer insights company 1Q has launched a prescription-verified panel of users of GLP-1 drugs, including weight ...

SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.

U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...

A “click-to-cancel” rule, which would have required businesses to make it easy for consumers to cancel unwanted subscriptions ...

WeightWatchers has emerged from bankruptcy after slimming down its debts, as it pledged to combine weight-loss jabs with ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

Getting into the exercise habit was also important since one day, most people on Ozempic or Wegovy will stop taking it - putting themselves at risk of putting the weight back on if they were not ...

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...